Treatment of fructose-induced hepatic steatosis mice with 150 mg kg−1 body weight of kefir peptides significantly inhibited the expression of the leptin receptor (OB-R) and increased the expression of p-JAK2, STAT3 and p-STAT3. Here, STAT3 is linked to fatty liver disease.